IACTA Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- IACTA Pharmaceuticals's estimated annual revenue is currently $1.1M per year.
- IACTA Pharmaceuticals's estimated revenue per employee is $100,500
- IACTA Pharmaceuticals's total funding is $1M.
Employee Data
- IACTA Pharmaceuticals has 11 Employees.
- IACTA Pharmaceuticals grew their employee count by 120% last year.
IACTA Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder & Chief Administrative Officer | Reveal Email/Phone |
2 | Co-Founder & Chief Business Officer | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Owner | Reveal Email/Phone |
IACTA Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is IACTA Pharmaceuticals?
Our goal is to vastly improve patient care and outcomes by bringing innovative eye care technology to the healthcare industry. We want to significantly advance the efficacy and safety of existing eye care drugs while developing new ophthalmic drugs that address many unmet medical needs. Through our unique and extensive partnerships, we are able to identify and launch new technologies into beneficial treatments that can help many patients worldwide.
keywords:N/A$1M
Total Funding
11
Number of Employees
$1.1M
Revenue (est)
120%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 11 | -8% | N/A |
#2 | $0.3M | 11 | -15% | $110M |
#3 | $1M | 11 | N/A | N/A |
#4 | $1M | 11 | N/A | N/A |
#5 | $1M | 11 | -21% | N/A |